Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...

Taking anti-inflammatory drugs after surgery is fairly standard protocol. But a new study from researchers at Michigan State ...

A giant functional atlas of immune cells in a Chinese cohort reveals crucial differences with European and Japanese data sets ...

A nanomaterial based on a platform developed by Professor Samuel Stupp crosses the blood-brain barrier and targets harmful ...

For generations, Brazilians have turned to a colorful garden plant to soothe aching joints, trusting experience long before ...

Investing.com -- InflaRx N.V. (NASDAQ:IFRX) stock dropped 2.5% Thursday after the biopharmaceutical company announced a ...

Part of the challenge lies with identifying otherwise healthy individuals — especially women — who lack standard modifiable ...

InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...

Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from ...

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...